A Remedy for Angioedema That&#x27;s Worth Its Salt

July 24th 2024

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The rate of ME/CFS was similar (3% to 4%) at 3 through 12 months for study participants who tested positive and negative for COVID-19.

October 25th 2023

Semaglutide Behind Huge Increase in GLP-RA Prescriptions with Fewer Written for Type 2 Diabetes

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

July 23rd 2024

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

The significant rise in new GLP-1 RA prescriptions between 2011 and 2023 saw a doubling in the proportion written for obesity and a decline in those for T2D.

August 30th 2023

Individuals with Atrial Fibrillation Who Use Wearable Devices Report Heightened Symptom Monitoring, Treatment Concerns

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Statins Safe for Primary CVD Prevention in Old, Very Old: Daily Dose

Participants with AF who used wearable devices reported higher anxiety levels and increased health care usage than nonusers, according to a new study.

ME/CFS Rates No Different After COVID-19 Infection than After Other Acute Infection-Like Illnesses

Your daily dose of the clinical news you may have missed.

Related Content

July 24th 2024

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The rate of ME/CFS was similar (3% to 4%) at 3 through 12 months for study participants who tested positive and negative for COVID-19.

October 25th 2023

Semaglutide Behind Huge Increase in GLP-RA Prescriptions with Fewer Written for Type 2 Diabetes

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

July 23rd 2024

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

The significant rise in new GLP-1 RA prescriptions between 2011 and 2023 saw a doubling in the proportion written for obesity and a decline in those for T2D.

August 30th 2023

Individuals with Atrial Fibrillation Who Use Wearable Devices Report Heightened Symptom Monitoring, Treatment Concerns

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Statins Safe for Primary CVD Prevention in Old, Very Old: Daily Dose

Participants with AF who used wearable devices reported higher anxiety levels and increased health care usage than nonusers, according to a new study.